Found 4887 chains in Genus chains table. Displaying 151 - 200. Applied filters: Proteins

Search results query: 4-Layer Sandwich

Total Genus Sequence Length pdb Title
67 239 5leyF Human 20s proteasome complex with oprozomib at 1.9 angstrom
54 196 5lf6J Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom
64 211 5l68K Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
62 231 5l6aE Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
59 226 5l5uH Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
67 216 5le5M Native human 20s proteasome at 1.8 angstrom
63 244 5lf0G Human 20s proteasome complex with epoxomicin at 2.4 angstrom
70 244 5l65B Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
59 226 5l65H Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
65 211 5l67K Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924
64 231 5m2bE Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19
59 196 5l5zN Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
77 230 5le1A Vim-2 metallo-beta-lactamase in complex with 2-(2-chloro-6-fluorobenzyl)-3-oxoisoindoline-4-carboxylic acid (compound 16)
64 244 5leyG Human 20s proteasome complex with oprozomib at 1.9 angstrom
60 237 5lf0C Human 20s proteasome complex with epoxomicin at 2.4 angstrom
64 241 5l5oG Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
70 244 5l6cB Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
69 244 5l5zB Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
71 244 5l6aB Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
71 240 5l61C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14
65 213 5lf0L Human 20s proteasome complex with epoxomicin at 2.4 angstrom
70 240 5l5eC Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
64 234 5le5E Native human 20s proteasome at 1.8 angstrom
56 204 5l6aI Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
62 222 5lzpA Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome
58 196 5l6cN Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
68 242 5l68D Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
65 242 5l60D Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
62 220 5lexH Native human 20s proteasome in mg-acetate at 2.2 angstrom
59 196 5l64N Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18
75 248 5lf3B Human 20s proteasome complex with bortezomib at 2.1 angstrom
58 204 5l5yI Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib
61 241 5l60G Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
71 240 5l60C Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924
55 204 5lezI Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom
60 226 5l63H Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
62 244 5lf1G Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom
61 222 5l66L Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib
61 220 5lf7H Human 20s proteasome complex with ixazomib at 2.0 angstrom
63 241 5lttG Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924
67 233 5l65M Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
69 233 5l5zM Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib
58 204 5l63I Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17
65 230 5lf3A Human 20s proteasome complex with bortezomib at 2.1 angstrom
58 204 5l65I Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib
62 241 5l68G Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14
69 242 5l6bD Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914
69 230 5le5A Native human 20s proteasome at 1.8 angstrom
58 226 5l62H Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16
60 222 5l60L Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924